Yang, Jing <br/><br/>
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.  [electronic resource] 

 -  Blood  Sep 2007 
 - 2034-40 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2007-02-073700  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibiotics, Antineoplastic--pharmacology<br/>Apoptosis--drug effects<br/>Aurora Kinase A<br/>Aurora Kinase B<br/>Aurora Kinases<br/>Case-Control Studies<br/>Cell Cycle--drug effects<br/>Cell Proliferation--drug effects<br/>Colony-Forming Units Assay<br/>Daunorubicin--pharmacology<br/>Drug Synergism<br/>Drug Therapy, Combination<br/>Drug Tolerance<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Immunoblotting<br/>Leukemia--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Organophosphates--pharmacology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Quinazolines--pharmacology<br/>Thymidine--metabolism<br/>Transplantation, Heterologous<br/>Tubulin Modulators--pharmacology<br/>Vincristine--pharmacology